Pharmaceutical giant GSK has unveiled its £44 million vaccine production facility in Montrose. The site, which will produce ingredients for vaccines to treat conditions such as tetanus, pneumonia and whooping cough, has been five years in the making. GSK had first announced plans for its facility, which is now being commissioned, in 2012. The facility will create a further 19 skilled jobs in Montrose by...
3f bio Ltd, a spinout company from the University of Strathclyde has secured an investment round of £461,000. 3f bio Ltd is involved in the sustainable production of food protein, at a reduced cost. The funding raised allows 3f bio Ltd to progress development of the product and increasing scale of production, as well as embarking on technological advances to global potentials for sustainable protein....
£1million investment has been secured by The University of Glasgow to develop treatment for tendon injuries. 1 in 10 people are affected with tendon injuries in their lifetime through sporting injuries, repetitive strain or major traumas. Causeway Therapeutics work to develop therapies for tendon injuries and discovered a single microRNA that plays a key role in strengthening tendons. To read the full article, click here.
Scottish bio-tech company has been awarded €4million to develop its pioneering cancer treatment. This is the largest EU award to any Scottish company for healthcare therapeutic product. The recipients of the award, TC BioPharm(TCB) announced the investment which will aide in their development of GTD cell therapy treatment for cancer. The research will allow the therapeutic cells derived from a single donor to treat several...